78 related articles for article (PubMed ID: 24301913)
21. Cisplatin-Chelated Iminodiacetic Acid-Conjugated Hyaluronic Acid Nanogels for the Treatment of Malignant Pleural Mesothelioma in Mice.
Amano Y; Sakura KL; Ohta S; Ito T
Mol Pharm; 2022 Mar; 19(3):853-861. PubMed ID: 35142223
[TBL] [Abstract][Full Text] [Related]
22. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
23. Forchlorfenuron and Novel Analogs Cause Cytotoxic Effects in Untreated and Cisplatin-Resistant Malignant Mesothelioma-Derived Cells.
Henzi T; Diep KL; Oberson A; Salicio V; Bochet CG; Schwaller B
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409322
[TBL] [Abstract][Full Text] [Related]
24. Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells.
Pillai K; Ehteda A; Akhter J; Chua TC; Morris DL
Anticancer Drugs; 2014 Feb; 25(2):150-60. PubMed ID: 24366282
[TBL] [Abstract][Full Text] [Related]
25. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
Chock KL; Allison JM; Shimizu Y; ElShamy WM
Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
[TBL] [Abstract][Full Text] [Related]
26. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
27. Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed.
Palumbo C; Battisti S; Carbone D; Albonici L; Alimandi M; Bei R; Modesti A
Cancer Chemother Pharmacol; 2008 Apr; 61(5):893-901. PubMed ID: 17922127
[TBL] [Abstract][Full Text] [Related]
28. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53.
Lee YJ; Park IS; Lee YJ; Shim JH; Cho MK; Nam HS; Park JW; Oh MH; Lee SH
Food Chem Toxicol; 2014 Jan; 63():153-60. PubMed ID: 24239893
[TBL] [Abstract][Full Text] [Related]
30. The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach.
Forte IM; Indovina P; Montagnaro S; Costa A; Iannuzzi CA; Capone F; Camerlingo R; Malfitano AM; Pentimalli F; Ferrara G; Quintiliani M; Portella G; Giordano A; Ciarcia R
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960727
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines.
Toma S; Colucci L; Scarabelli L; Scaramuccia A; Emionite L; Betta PG; Mutti L
J Cell Physiol; 2002 Oct; 193(1):37-41. PubMed ID: 12209878
[TBL] [Abstract][Full Text] [Related]
32. SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.
Van TT; Hanibuchi M; Goto H; Kuramoto T; Yukishige S; Kakiuchi S; Sato S; Sakaguchi S; Dat le T; Nishioka Y; Akiyama S; Sone S
Respirology; 2012 Aug; 17(6):984-90. PubMed ID: 22574723
[TBL] [Abstract][Full Text] [Related]
33. Phase-contrast microscopy studies of early cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis.
Janson V; Behnam-Motlagh P; Henriksson R; Hörstedt P; Engström KG; Grankvist K
Exp Lung Res; 2008 Feb; 34(2):49-67. PubMed ID: 18266129
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
[TBL] [Abstract][Full Text] [Related]
35. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
36. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
Wang MB; Yip HT; Srivatsan ES
Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
Damaraju D; Damaraju VL; Brun M; Mowles D; Kuzma M; Berendt RC; Sawyer MB; Cass CE
Biochem Pharmacol; 2008 May; 75(10):1901-11. PubMed ID: 18371936
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells.
Johansson D; Andersson C; Moharer J; Johansson A; Behnam-Motlagh P
Br J Cancer; 2010 Jan; 102(2):383-91. PubMed ID: 20010943
[TBL] [Abstract][Full Text] [Related]
39. The tocotrienol-rich fraction from rice bran enhances cisplatin-induced cytotoxicity in human mesothelioma H28 cells.
Nakashima K; Virgona N; Miyazawa M; Watanabe T; Yano T
Phytother Res; 2010 Sep; 24(9):1317-21. PubMed ID: 20127663
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells.
Chae JI; Jeon YJ; Shim JH
Oncol Rep; 2013 Jun; 29(6):2318-24. PubMed ID: 23525508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
